Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • subuhikhan
    Junior Member
    • Dec 2011
    • 4

    #1

    3' bias in Illumina sequencing

    Hello,

    I am working on a plant virus RNA sequencing data (Illumina). I have trimmed my reads from 101bp to around 90bp to improve the quality of each read with the library. I created assembly of my sequence libraries against the reference Viral genome sequence (10kb in size). The mappability of reads is showing bias towards 3'end of the viral genome i.e. more reads are binding towards the 3' end? What can be the possible reason for that?? And how can I reduce the bias at the 3' end?

    Thank you
    Subuhi
  • rskr
    Senior Member
    • Oct 2010
    • 249

    #2
    Originally posted by subuhikhan View Post
    Hello,

    I am working on a plant virus RNA sequencing data (Illumina). I have trimmed my reads from 101bp to around 90bp to improve the quality of each read with the library. I created assembly of my sequence libraries against the reference Viral genome sequence (10kb in size). The mappability of reads is showing bias towards 3'end of the viral genome i.e. more reads are binding towards the 3' end? What can be the possible reason for that?? And how can I reduce the bias at the 3' end?

    Thank you
    Subuhi
    In various transcriptome experiments we *may* have observed some strand bias. I don't think it has much to do with the sequencing. If it is true that the bias is there, I think it might be do to the PCR reactions for RNA being incomplete in the first cycle, and this again will depend on the method of amplification for the primers. But if there were a bunch of strand specific template, and a certain fraction were only amplified partially in the first cycle then you would see a bias, since at every iteration of the reaction the sequences wouldn't get longer.

    I don't know if this helps, its a hypothesis, but I am interested to see if any one else has similar suspicions.

    Comment

    • subuhikhan
      Junior Member
      • Dec 2011
      • 4

      #3
      Hello,

      But if we are first fragmenting the RNA and then making its cDNA even then we will see this bias (i.e. the bias caused by RNA primers used for sequencing)?

      Thank u
      Subuhi

      Comment

      • rskr
        Senior Member
        • Oct 2010
        • 249

        #4
        Originally posted by subuhikhan View Post
        Hello,

        But if we are first fragmenting the RNA and then making its cDNA even then we will see this bias (i.e. the bias caused by RNA primers used for sequencing)?

        Thank u
        Subuhi
        Hmm... first fragmenting RNA, then making cDNA. Correct me if I am wrong, but cDNA molecules will have three prime ends on either end of the double stranded DNA. Doesn't sound like a sequencing bias. Your RNA may be enzymatically active and or forming structures, which could potentially behave as a bias perhaps.

        Comment

        • HESmith
          Senior Member
          • Oct 2009
          • 512

          #5
          Originally posted by rskr View Post
          Hmm... first fragmenting RNA, then making cDNA. Correct me if I am wrong, but cDNA molecules will have three prime ends on either end of the double stranded DNA. Doesn't sound like a sequencing bias. Your RNA may be enzymatically active and or forming structures, which could potentially behave as a bias perhaps.
          Not wrong, but irrelevant to the poster's question. It's a 10 kbp viral RNA genome, and an excess of reads maps to the 3' end of that genome.

          A few possibilities come to mind: 1) the sample is degraded from the 5' end; 2) assuming a polyadenylated plus-strand genome, first strand synthesis was primed with oligo(dT) instead of the more typical oligo(dT) plus random hexamer mix; 3) the sequenced genome is flanked by LTRs, but the reference used for alignment contains only one copy at the 3' end.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
            by SEQadmin2



            Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

            Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
            ...
            10-14-2026, 09:55 AM
          • SEQadmin2
            New Genomics Technologies Take Aim at Long-Standing Limits
            by SEQadmin2


            Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

            We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
            ...
            09-28-2026, 10:25 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, 10-22-2026, 11:13 AM
          0 responses
          34 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-22-2026, 10:48 AM
          0 responses
          25 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-15-2026, 10:52 AM
          0 responses
          41 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 10-14-2026, 05:39 AM
          0 responses
          45 views
          0 reactions
          Last Post SEQadmin2  
          Working...